Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyanocobalamin adverse reaction |
Causative agent (attribute) |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Allergy to cyanocobalamin |
Causative agent (attribute) |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
cyanocobalamin 1mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin 500mcg/0.1mL intranasal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing cyanocobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin 500mcg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin 1mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing cyanocobalamin and folic acid and vitamin B6 compound (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin 100mcg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin 100mcg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin 25micrograms nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing cyanocobalamin in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Allergy to cyanocobalamin |
Causative agent (attribute) |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin + folic acid |
Is a |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Cyanocobalamin 5 mg/g nasal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing ascorbic acid and cyanocobalamin and ferrous fumarate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Product containing ascorbic acid and cyanocobalamin and ferrous fumarate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyanocobalamin 1 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyanocobalamin 1 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin (60-Co) (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin (57-Co) (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin (58-Co) (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
|
Product containing only ascorbic acid and cyanocobalamin and ferrous fumarate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Product containing only cyanocobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing only cyanocobalamin and folic acid and vitamin B6 compound (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Ascorbic acid and cyanocobalamin and ferrous fumarate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Product containing only cyanocobalamin in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing only cyanocobalamin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Plasma vitamin B12 level (procedure) |
Component |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
3 |
Serum vitamin B12 measurement |
Component |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Vitamin B12 measurement |
Component |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Aquacobalamin measurement, serum (procedure) |
Component |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
3 |
Cyanocobalamin 1 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin 1 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin 5 mg/g nasal gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin 5 mg/g nasal gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin 500 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin 500 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Vitamin B12 intake |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
2 |
Cyanocobalamin- and folic acid- and pyridoxine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Cyanocobalamin and folic acid and pyridoxine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyanocobalamin 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyanocobalamin 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Injection of vitamin B12 (procedure) |
Direct substance |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Plasma vitamin B12 level (procedure) |
Component |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |
Serum vitamin B12 measurement |
Component |
True |
Cyanocobalamin (substance) |
Inferred relationship |
Some |
1 |